Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endolymphatic hydrops is prevalent in the first weeks following cochlear implantation.

Hearing research·2015
Same author

Nobel laureates' letter to President Bush.

The Washington post·2002
Same author

Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity.

The European journal of neuroscience·2001
Same author

S-nitrosoglutathione reduces nonocclusive thrombosis rate following balloon overstretch injury and intracoronary irradiation of porcine coronary arteries.

International journal of radiation oncology, biology, physics·2000
Same author

Induction of nitric oxide production in infiltrating leukocytes following in vivo irradiation of tumor-bearing mice.

Radiation oncology investigations·1999
Same author

Science over politics.

Science (New York, N.Y.)·1999

Related Experiment Video

Updated: Jul 14, 2026

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
09:48

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

Neuroprotective antioxidants from marijuana.

A J Hampson1, M Grimaldi, M Lolic

  • 1Laboratory of Cellular and Molecular Regulation, NIMH, Bethesda, Maryland 20892, USA. aidan@codon.nih.gov

Annals of the New York Academy of Sciences
|June 23, 2000
PubMed
Summary

Cannabidiol and THC show neuroprotective effects against glutamate toxicity by acting as potent antioxidants, independent of cannabinoid receptors. Cannabidiol demonstrated superior antioxidant capacity compared to other antioxidants in neuronal cultures.

More Related Videos

Spinal Cord Neurons Isolation and Culture from Neonatal Mice
07:49

Spinal Cord Neurons Isolation and Culture from Neonatal Mice

Published on: July 11, 2017

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Related Experiment Videos

Last Updated: Jul 14, 2026

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
09:48

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

Spinal Cord Neurons Isolation and Culture from Neonatal Mice
07:49

Spinal Cord Neurons Isolation and Culture from Neonatal Mice

Published on: July 11, 2017

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Glutamate is a neurotransmitter that can cause neurotoxicity at toxic levels.
  • Cannabinoids, including delta 9-tetrahydrocannabinol (THC) and cannabidiol, are compounds found in marijuana.
  • Cannabinoid receptors are known to mediate various physiological effects.

Purpose of the Study:

  • To investigate the neuroprotective potential of cannabidiol and other cannabinoids against glutamate-induced neurotoxicity.
  • To determine the mechanism of action underlying the neuroprotective effects of cannabinoids.
  • To evaluate the antioxidant properties of cannabinoids and their efficacy compared to other antioxidants.

Main Methods:

  • Rat cortical neuron cultures were exposed to toxic levels of glutamate.
  • Neurotoxicity was assessed in the presence of various cannabinoids, including THC and cannabidiol.
  • Cyclic voltammetry and Fenton reaction systems were used to measure antioxidant activity.
  • Cannabidiol's protective capacity was compared against alpha-tocopherol and ascorbate.

Main Results:

  • Both THC and cannabidiol reduced NMDA, AMPA, and kainate receptor-mediated neurotoxicities.
  • Neuroprotection was observed to be independent of cannabinoid receptor antagonism.
  • Cannabidiol, THC, and other cannabinoids were identified as potent antioxidants.
  • Cannabidiol demonstrated superior antioxidant capacity in preventing glutamate toxicity compared to alpha-tocopherol and ascorbate.
  • Preliminary in vivo studies in a rat model of focal cerebral ischemia suggest similar efficacy for cannabidiol.

Conclusions:

  • Cannabidiol and THC exert neuroprotection through a mechanism independent of cannabinoid receptors, primarily via potent antioxidant activity.
  • Cannabidiol exhibits significant antioxidant properties, outperforming established antioxidants like alpha-tocopherol and ascorbate in protecting neurons from glutamate toxicity.
  • These findings suggest that cannabidiol holds promise as a therapeutic agent for conditions involving neurotoxicity and oxidative stress, including ischemic stroke.